Evoke Pharma Annual Meeting results: directors elected, auditor ratified, say-on-pay approved, 3-year frequency

Evoke Pharma Inc

Class III directors Malcolm R. Hill (327,711 for) and Vickie W. Reed (335,555 for) elected.
Ratification of BDO USA as auditor for 2025 approved: 935,706 for, 12,174 against, 12,190 abstain.
Advisory vote on executive compensation approved: 308,413 for, 144,621 against, 3,361 abstain (503,675 broker non-votes).
Stockholders recommended a three-year frequency for future advisory votes on executive compensation (242,339 votes for three years).

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.